Needham & Company Reiterates a 'Buy' on Seattle Genetics (SGEN); Raising PT
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Rating Summary:
10 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Seattle Genetics (NASDAQ: SGEN), PT increased from $18 to $22.
Needham analyst says, "We believe milestone events such as the recent BLA filings for HL and ALCL, progress in trials of ADCETRIS (b. vedotin) in other
indications as well as trials of other pipeline products, and multiple, newly-formed ADC collaborations have advanced the Seattle Genetics to a new level."
For more ratings news on Seattle Genetics click here and for the rating history of Seattle Genetics click here.
Shares of Seattle Genetics closed at $16.43 yesterday.
Needham analyst says, "We believe milestone events such as the recent BLA filings for HL and ALCL, progress in trials of ADCETRIS (b. vedotin) in other
indications as well as trials of other pipeline products, and multiple, newly-formed ADC collaborations have advanced the Seattle Genetics to a new level."
For more ratings news on Seattle Genetics click here and for the rating history of Seattle Genetics click here.
Shares of Seattle Genetics closed at $16.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Celcuity Inc (CELC) PT Lowered to $140 at Needham
- Alpha & Omega Semiconductor (AOSL) PT Lowered to $45 at Needham
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
